Aptose Biosciences Stock Price Prediction
| APS Stock | CAD 0.25 0.01 3.85% |
Oversold Vs Overbought
41
Oversold | Overbought |
EPS Estimate Next Quarter (1.60) | EPS Estimate Current Year (1.79) | EPS Estimate Next Year (3.05) | Wall Street Target Price 31.02 | EPS Estimate Current Quarter (1.57) |
Using Aptose Biosciences hype-based prediction, you can estimate the value of Aptose Biosciences from the perspective of Aptose Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aptose Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Aptose because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aptose Biosciences after-hype prediction price | CAD 0.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aptose |
Aptose Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Aptose Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aptose Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aptose Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aptose Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Aptose Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aptose Biosciences' historical news coverage. Aptose Biosciences' after-hype downside and upside margins for the prediction period are 0.01 and 5.59, respectively. We have considered Aptose Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aptose Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Aptose Biosciences is based on 3 months time horizon.
Aptose Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aptose Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aptose Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aptose Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.10 | 5.27 | 0.03 | 0.10 | 1 Events / Month | 0 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.25 | 0.28 | 12.00 |
|
Aptose Biosciences Hype Timeline
Aptose Biosciences is presently traded for 0.25on Toronto Exchange of Canada. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -0.1. Aptose is projected to increase in value after the next headline, with the price projected to jump to 0.28 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 12.0%, whereas the daily expected return is presently at -1.1%. The volatility of related hype on Aptose Biosciences is about 5855.56%, with the expected price after the next announcement by competition of 0.15. Aptose Biosciences has accumulated 1.01 M in total debt with debt to equity ratio (D/E) of 5.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aptose Biosciences has a current ratio of 11.04, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aptose Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Aptose Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aptose Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aptose to invest in growth at high rates of return. When we think about Aptose Biosciences' use of debt, we should always consider it together with cash and equity.Assuming the 90 days trading horizon the next projected press release will be very soon. Check out Aptose Biosciences Basic Forecasting Models to cross-verify your projections.Aptose Biosciences Related Hype Analysis
Having access to credible news sources related to Aptose Biosciences' direct competition is more important than ever and may enhance your ability to predict Aptose Biosciences' future price movements. Getting to know how Aptose Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aptose Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MDNA | Medicenna Therapeutics Corp | (0.24) | 2 per month | 0.00 | (0.05) | 7.66 | (8.26) | 27.82 | |
| ONC | Oncolytics Biotech | 0.06 | 2 per month | 3.17 | 0 | 6.47 | (5.16) | 37.61 |
Aptose Biosciences Additional Predictive Modules
Most predictive techniques to examine Aptose price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aptose using various technical indicators. When you analyze Aptose charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aptose Biosciences Predictive Indicators
The successful prediction of Aptose Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aptose Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aptose Biosciences based on analysis of Aptose Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aptose Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aptose Biosciences's related companies. | 2023 | 2024 (projected) | Graham Number | 8.56 | 8.13 | Receivables Turnover | 0.45 | 0.4 |
Story Coverage note for Aptose Biosciences
The number of cover stories for Aptose Biosciences depends on current market conditions and Aptose Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aptose Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aptose Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Aptose Biosciences Short Properties
Aptose Biosciences' future price predictability will typically decrease when Aptose Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aptose Biosciences often depends not only on the future outlook of the potential Aptose Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aptose Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.8 M | |
| Cash And Short Term Investments | 9.3 M |
Check out Aptose Biosciences Basic Forecasting Models to cross-verify your projections. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.